Silverarc Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Silverarc Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-199,020	Closed	-$7.89M	–	91
2024 Q1	$7.89M	Sell	199,020 -98,769	-33%	-$2.91M	2.19%	15
2023 Q4	$5.68M	Buy	+297,789	New	+$4.14M	1.69%	23

Silverarc Capital Management's ALPN Position: Q2 2024 in Review

Silverarc Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 199,020 shares — an estimated $7.89M sold.

Silverarc Capital Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $7.89M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Silverarc Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Silverarc Capital Management sold 199,020 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $7.89M.
Silverarc Capital Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Silverarc Capital Management's Alpine Immune Sciences Inc position peaked at $7.89M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Silverarc Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.